Prevention of Shivering Associated With Spinal Anesthesia

PHASE2/PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

November 30, 2023

Primary Completion Date

November 30, 2024

Study Completion Date

December 31, 2024

Conditions
Shivering, Spinal Anesthesia
Interventions
DRUG

Dexmedetomidine

Patients will receive dexmedetomidine 0.5 mcg/kg diluted in 10 mL of NS given as IV infusion over 10 min before induction of spinal anesthesia

DRUG

Ketamine

Patient will will receive ketamine 0.5 mg/kg diluted in 10 mL of NS given as IV infusion over 10 min before induction of spinal anesthesia

DRUG

Meperidine

If the tested drug hasn't stopped shivering patient will receive 0.25 mg/kg meperidine

All Listed Sponsors
lead

Assiut University

OTHER

NCT06082076 - Prevention of Shivering Associated With Spinal Anesthesia | Biotech Hunter | Biotech Hunter